Andrew Newman MD
Diabetes, Lipid Metabolism
Clinical/Research Fellow in Endocrinology
Join to View Full Profile
75 Francis StBoston, MA 02115
Phone+1 617-732-5666
Dr. Newman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2022 - 2025
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2019 - 2022
Florida International University Herbert Wertheim College of MedicineClass of 2019
Certifications & Licensure
MA State Medical License 2022 - 2025
NJ State Medical License 2021 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism.Cheng-Hsuan Tsai, Jenifer M Brown, Stefanie Parisien-La Salle, Andrew Newman, Vin-Cent Wu
Hypertension. 2025-03-31 - 1 citationsProgressive 11β-Hydroxysteroid Dehydrogenase Type 2 Insufficiency as Kidney Function Declines.Thomas Uslar, Andrew J Newman, Alejandra Tapia-Castillo, Cristian A Carvajal, Carlos E Fardella
The Journal of Clinical Endocrinology and Metabolism. 2025-03-17 - Subclinical Primary Aldosteronism is Characterized by Maladaptive Natriuretic Peptide and Adrenal Hormonal Physiology.Stefanie Parisien-La Salle, Jenifer M Brown, Sanan Mahrokhian, Isabelle Hanna, Brooke Honzel
The Journal of Clinical Endocrinology and Metabolism. 2025-02-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
